Abstract
INTRODUCTION
Heart failure represents a tremendous public health burden and a global pandemic worldwide and, moreover is increasing in prevalence [1] . Also, heart failure patients require an increased number of hospital admissions with a high number of hospitalization days. Although, in the recent years various treatments and initiatives to improve care delivery were developed, heart failure's evolution remains associated with an important morbidity and mortality [1] . Moreover, the presence of obesity in heart failure patients is frequently observed, bringing additional challenges in terms of heart failure diagnosis, treatment and prognosis. This is due to the fact that usually obese patients are presenting dyspnoea, oedema, a decreased exercise capacity, but also low acoustic echocardiographic images which limits the diagnostic accuracy [1] . Obesity is an independently acknowledged cardiovascular risk factor, also having strong links to the development of heart failure. Moreover, obesity and heart failure are two conditions frequently associated, so a comprehensive approach is needed for these patients taking into account certain particular features of their diagnosis, prognosis and treatment. One of the particularities described in this subpopulation is the existence of an "obesity paradox"-a clinical phenomenon in which obese patients with heart failure have a better prognosis than normal weight or underweight patients [2] . The prognosis of these patients is improved by a proper advanced treatment, but undoubtedly cardiovascular rehabilitation programs have a major role too [3] . They should include, besides physical training The profile of cardiovascular risk factors in heart failure obese patients hospitalised in a rehabilitation romanian hospital programs, the implementation of lifestyle change measures, which are of extreme importance in order to correct other cardiovascular risk factors associated with obesity [4] .
The aim of the current study is to identify the cardiovascular risk factors profile in heart failure obese patients, hospitalized in the Rehabilitation Hospital, Cardiology-Department, who will be included in cardiovascular rehabilitation programs.
MATERIALS AND METHODS
The study included 80 obese patients with an averaged age of 69.75 ± 9.12 years, 56.2% of them being represented by men, who were hospitalized with a primary diagnosis of decompensated heart failure in the Rehabilitation Hospital, CardiologyDepartment, Cluj-Napoca, Romania. Inclusion criteria were a body mass index (BMI) ≥30 kg/m 2 , diagnosis of heart failure (HF), in accordance with the 2016 ESC criteria. Exclusion criteria were age under 18 years, the presence of other comorbidities susceptible to significant systolic dysfunction, chronic kidney disease with a glomerular filtration rate < 30 ml/min/1.73 m 2 (KDOQI stage 4 and 5) and recent acute coronary syndrome. Baseline characteristics, clinical presentation, the aetiologies of heart failure, the functional NYHA class, NTproBNP values, electrocardiographic findings, echocardiographic parameters and in-hospital therapies were evaluated. NT-pro-BNP values higher than 125 pg/ml were considered to be associated with heart failure development. NT-pro-BNP levels were determined using the ELISA method. Hyperuricemia was defined as ≥7.0 mg/dL in males and ≥5.8 mg/dL in females. Statistics were performed using SPSS 16.0 for Windows. Analysis of the differences between qualitative variables was performed using the χ2 test. The Kolmogorov-Smirnov test was used to assess the normal distribution of continuous numerical variables. Values of P< 0.05 were considered statistically significant.
RESULTS
The baseline demographic and clinical characteristics of the patients are summarized in table 1. The aetiology of heart failure was ischemic in 46.25% of cases and non-ischemic (toxic, abnormal loading conditions, such as hypertension, valve pathologies, various tachy-or bradyarrhythmias and genetic abnormalities) in 53.57% of patients. The most frequent associated risk factor was smoking (45%), followed by diabetes mellitus (40%). The plasma mean levels of all lipid fractions were between normal ranges: total-cholesterol (CST) -167.82 ± 48.85 mg/dl, LDL-CST -102.40±39.5 mg/dl, triglycerides (TG) -145.68±81.91mg/dl, HDL-CST -38.64 ± 11.42 mg/dl, as shown in table 1. The mean value of serum uric acid concentrations were high -8.07± 2.35 mg/dl. Table I . Baseline characteristics of the study population
The mean ejection fraction value was 43.58±10.85%. The mean NT-pro-BNP value was elevated -2887.03 ± 3157 pg/ml. NT-proBNP values correlated indirect with total-cholesterol -r== -0.194 -figure 1, LDLcholesterol-r=-0.0971, triglycerides-r=-0.155, HDLcholesterol-r=-0.07. In male patients an indirect, significantly statistical correlation was found between NT-pro-BNP levels and total-cholesterol (r=-0.319, p=0.036)-figure 2. Also, NT-pro-BNP indirect correlated with left ventricular ejection fraction (LVEF) -r=-0.307, p=0.0086 -figure 3. This relationship was statistical significant in male patients (r=-0.423, P=0.0067) in comparison with women where this association was not found (r= -0.156, p>0.05). 
DISCUSSION
The link between obesity and cardiovascular pathology may be explained, on one hand, by the presence of other traditional cardiovascular risk factors such as arterial hypertension, dyslipidemia, type II diabetes, metabolic syndrome or sleep apnea syndrome in obese individuals [5] . The Framingham study showed an increased risk of developing heart failure of 5% for males and 7% for females for each BMI increase by one kg/m 2 [6] . In comparison with lean subjects, the risk of heart failure doubles in those with obesity, with a relative risk of 2.12 for women and 1.90 for males [7] . Moreover, obese patients present distinct features in terms of pathophysiology, etiology, diagnosis and treatment of heart failure, compared with their normal weight counterparts. So, they seem to have a predisposition for the phenotype with preserved ejection fraction, a more frequent ischemic etiology, earlier symptoms of HF, lower levels of natriuretic peptides, particular treatment challenges, but also more false-positive diagnoses of HF [8] . Therefore, the treatment of heart failure in this population should not only focus on pharmacological approach, but also on lifestyle changes and including these patients in physical training programs [9] . In Romania, after hospital discharge, heart failure patients are addressed for cardiovascular rehabilitation programs in specialized centers, such as Covasna Cardiovascular Disease Hospital. Physical exercise is recommended by the current guidelines in order to improve NYHA functional class and diastolic dysfunction [1] . To note that, obese patients often present a marked decreased exercise tolerance, with frequently abnormal blood pressure response and chronotropic stress incompetence. In the current study, 25% of patients were hypertensive. In Romania, the overall prevalence of hypertension continues to climb [10] . Recent studies show that high systolic and diastolic blood pressure in patients with heart failure increases the incidence of major adverse cardiac events, including cardiovascular mortality [11, 12] .
Another commonly comorbidity found in heart failure patients is diabetes mellitus, the with a prevalence ranging between 30-40% [13] . Also, in our study the prevalence of diabetes was high (40%). The presence of DM in heart failure patients rises the number of hospitalisations and the risk of mortality, compared to those without diabetes [14] .
The most frequent associated cardiovascular risk factor in our study was smoking -45% of the study's population was smoking. The smoking status is an important factor for heart failure's prognosis, smoking cessation being one of the main lifestyle changes recommendations in heart failure and not only [1, 9] .
In the current paper, LDL-cholesterol and triglycerides levels were between normal ranges or even lower. There is strong evidence showing that lower levels of cholesterol in decompensated heart failure patients are independently associated with a worse prognosis [15] . Windler and al. showed that heart failure patients with lower total-cholestreol levels (163.6 mg/dl) have a higher mortality rate compared to those with higher total-cholesterol values (218 mg/dl) [16] . There are several pathways leading to altered cholesterol metabolism in heart failure patients, such as congestive hepatopathy, excessive proinflammatory cytokine synthesis or increased endotoxine activity [17] [18] [19] .
Obesity is an independently acknowledged cardiovascular risk factor, but the presence of this condition in heart failure patients has been shown to be of better prognosis-the "obesity paradox" hypothesis. Thus, although weight loss is often recommended to improve the symptoms and to reduce cardiovascular risk factors, it is not associated with improved prognosis in heart failure [2] . Moreover, weight loss in patients with heart failure is associated with poor prognosis, increasing the risk of mortality and morbidity [2] . The ESC heart failure guideline highlights that weight loss may be considered only in patients with severe obesity (BMI between 35-45 kg/m 2 ), in order to manage symptoms and increase exercise capacity [1] .
The mean NT-pro-BNP value was greatly elevated in our study. Generally, NT-pro-BNP serum levels are influenced by several factors, such as age, gender, arterial hypertension, renal function, body mass index, and thyroid function. Recent studies show decreased natriuretic peptide values in obese patients with heart failure [1, 20] . An indirect correlation is described between plasma levels of natriuretic peptide biomarkers and BMI [21] . The pathophysiological mechanism of this relationship is not fully understood. A possible explanation could be that the C-type natriuretic peptide receptors (NPR-C) are well represented in the adipose tissue, lipolysis being partially accomplished at this level, leading to a lower serum concentration of natriuretic peptides in obese patients. But, on the other hand, NT-pro-BNP and NT-pro-ANP are different molecules than natriuretic peptides, so the above mentioned mechanism cannot explain their lower levels in obese heart failure patients. Reduced cardiac synthesis or secretion of natriuretic peptides may at least, partially explain this phenomenon [21, 22] . In the current study, NT-pro-BNP values were inverse correlated with total-cholesterol, LDL-cholesterol, triglycerides values and ejection fraction, which was interpreted as a marker of poor prognosis. Obese heart failure patients develop most frequently heart failure with preserved or mildly reduced left ventricular ejection fraction. In our study the median ejection fraction was of 45 %. There is evidence that heart failure with preserved ejection fraction is associated with an accelerated production and also an abnormal degradation of collagen [23] . ESC current guideline for the diagnosis and treatment of acute and chronic heart failure highlights that one out of six patients experiencing exertion symptoms of heart failure, who fits in the heart failure with preserved ejection fraction class remains undiagnosed [1] . In conclusion, obese heart failure patients presented particular characteristics, the most frequent associated cardiovascular risk factors were smoking, diabetes mellitus and arterial hypertension. So, a comprehensive evaluation with identification and an appropriate approach of their comorbidities is of major importance for the improvement of heart failure's prognosis.
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